Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,398,568 papers from all fields of science
Search
Sign In
Create Free Account
Extensively Drug Resistance Process
Known as:
EXTENSIVE DRUG RESISTANCE
, XDR
Resistance to nearly all known drugs, particularly the most efficacious or non-first line drugs, used in the treatment of a particular disease.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
CDISC SDTM Drug Resistance Status Terminology
Clinical Data Interchange Standards Consortium Terminology
Pharmacologic Substance
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Integron-Mediated Antibiotic Resistance in Acinetobacter baumannii Isolated from Intensive Care Unit Patients, Babol, North of Iran
Mitra Deylam Salehi
,
Elaheh Ferdosi-Shahandashti
,
Y. Yahyapour
,
S. Khafri
,
Abazar Pournajaf
,
R. Rajabnia
BioMed Research International
2017
Corpus ID: 26015477
Background We investigated the integron types and their relation with antibiotic resistance among A. baumannii isolates collected…
Expand
Highly Cited
2014
Highly Cited
2014
Colistin nephrotoxicity increases with age
I. Balkan
,
M. Doğan
,
+13 authors
F. Tabak
Scandinavian Journal of Infectious Diseases
2014
Corpus ID: 33784518
Abstract Background: Colistin (COL) has become the backbone of the treatment of infections due to extensively drug-resistant (XDR…
Expand
2014
2014
Effectiveness of infection prevention measures featuring advanced source control and environmental cleaning to limit transmission of extremely-drug resistant Acinetobacter baumannii in a Thai…
A. Apisarnthanarak
,
Uayporn Pinitchai
,
Boonyasit Warachan
,
D. Warren
,
T. Khawcharoenporn
,
M. Hayden
American Journal of Infection Control
2014
Corpus ID: 25736251
2013
2013
From multidrug-resistant to extensively drug-resistant tuberculosis in Lisbon, Portugal: the stepwise mode of resistance acquisition.
J. Perdigão
,
R. Macedo
,
+5 authors
I. Portugal
Journal of Antimicrobial Chemotherapy
2013
Corpus ID: 2925103
OBJECTIVES The development and transmission of extensively drug-resistant (XDR) tuberculosis (TB) constitutes a serious threat to…
Expand
Highly Cited
2012
Highly Cited
2012
SUBMILLIMETER LINE SPECTRUM OF THE SEYFERT GALAXY NGC 1068 FROM THE HERSCHEL-SPIRE FOURIER TRANSFORM SPECTROMETER
L. Spinoglio
,
M. Pereira-Santaella
,
+13 authors
M. Page
2012
Corpus ID: 2251712
The first complete submillimeter spectrum (190–670 μm) of the Seyfert 2 galaxy NGC 1068 has been observed with the SPIRE Fourier…
Expand
2012
2012
Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion
Jia Feng
,
Lishuang Xu
,
Renchao Gao
,
Yanfei Luo
,
Xing Tang
Drug Development and Industrial Pharmacy
2012
Corpus ID: 12795245
Objective: The aim of this study was to evaluate several polymer carriers with regard to the bioavailability enhancement of…
Expand
Highly Cited
2011
Highly Cited
2011
Effective Antibiotics in Combination against Extreme Drug-Resistant Pseudomonas aeruginosa with Decreased Susceptibility to Polymyxin B
Tze-Peng Lim
,
Winnie Lee
,
+6 authors
A. Kwa
PLoS ONE
2011
Corpus ID: 3262113
Objective Extreme drug-resistant Pseudomonas aeruginosa (XDR-PA) with decreased susceptibility to polymyxin B (PB) has emerged in…
Expand
2011
2011
Safety and efficacy of thioridazine as salvage therapy in Indian patients with XDR-TB.
Z. Udwadia
,
T. Sen
,
L. Pinto
Recent Patents on Anti-Infective Drug Discovery
2011
Corpus ID: 32688074
New drugs are desperately needed to combat XDR-TB as effective treatment involves at least four drugs to which the patient is…
Expand
2009
2009
Resistance to pyrazinamide and ethambutol compromises MDR/XDR-TB treatment.
K. G. Hoek
,
H. S. Schaaf
,
N. G. V. Pittius
,
P. D. Helden
,
R. Warren
South African medical journal = Suid-Afrikaanse…
2009
Corpus ID: 11303608
The rising number of multi-drug resistant tuberculosis (MDR-TB) cases worldwide prompted the World Health Organisation (WHO) to…
Expand
2009
2009
SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB).
M. Martins
,
M. Viveiros
,
+4 authors
L. Amaral
International Journal of Antimicrobial Agents
2009
Corpus ID: 205167769
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE